Report of five children with Guillain-Barré syndrome following a nationwide oral polio vaccine campaign in Turkey

Neurology India

Volumn 51, Issue 4, 2003, Pages 544-545

  Anlar, Omer ^a   Tombul, T ^a   Arslan, S ^a   Akdeniz, H ^a   Caksen, H ^a   Gundem, A ^a   Akbayram, S ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Guillain Barr syndrome; Oral polio vaccine

Indexed keywords

IMMUNOGLOBULIN G; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

ARTICLE; BLOOD ANALYSIS; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL EXAMINATION; ELECTROMYOGRAPHY; FATALITY; FECES ANALYSIS; FEMALE; GUILLAIN BARRE SYNDROME; HEALTH PROGRAM; HUMAN; INFANT; MALE; MASS IMMUNIZATION; MORTALITY; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRESCHOOL CHILD; RESPIRATORY FAILURE; TURKEY (REPUBLIC); URINALYSIS; VIROLOGY;

CHILD, PRESCHOOL; FATAL OUTCOME; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; INFANT; MALE; MASS IMMUNIZATION; POLIOMYELITIS; POLIOVIRUS VACCINE, ORAL; TURKEY;

EID: 1042280371     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Kinnunen E, Juntilla O, Haukka J, Hovi T. Nationwide oral poliovirus vaccination campaign and the incidence of Guillain-Barré syndrome. Am J Epidemiol 1998;147:69-73.
2. Rantala H, Cherry JD, Shields WD, Uhari M. Epidemiology of Guillain-Barré syndrome in children: relationship of oral polio vaccine administration and occurrence. J Pediatr 1994;124:220-3.
3. Hurwitz ES, Holman RC, Nelson DB, Schonberger LB. National surveillance for Guillain-Barré syndrome: January 1978-March 1979. Neurology 1983;33:150-7.
4. Leneman F. The Guillain-Barré syndrome. Arch Intern Med 1966;118: 139-44.
5. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA, Ziegler DW, Retailliau HF. Guillain-Barre syndrome following vaccination in the national influenza immunization program, United States, 1976-1977. Am J Epidemiol 1979;110:105-23.
6. Kinnunen E, Farkkila M, Hovi T, Juntunen J, Weckstrom P. Incidence of Guillain-Barre syndrome during a nationwide oral poliovirus vaccine campaign. Neurology 1989;39:1034-6.
7. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 1990;27:S21-4.
8. Hurwitz ES, Holman RC, Nelson DB, Schonberger LB. Guillain-Barré syndrome and the 1978-1979 influenza vaccine. N Engl J Med 1981;304: 1557-61.
9. Hovi T, Cantell K, Huovilainen A, Kinnunen E, Kuronen T, Lapinleimu K, et al. Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet 1986;1:1427-32.
10. Salisbury DM. Association between oral poliovaccine and Guillain-Barre syndrome? Lancet 1998;351:79-80.
11. Stratton KR, Howe CJ, Johnston RB Jr. Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine. JAMA 1994;271:1602-5.
12. Ismail EA, Shabani IS, Badawi M, Sanaa H, Madi S, Al-Tawari A, et al. An epidemiologic, clinical, and therapeutic study of childhood Guillain-Barre syndrome in Kuwait: is it related to the oral polio vaccine? J Child Neurol 1998;13:488-92.
13. Dowling PC, Cook SD. Role of infection in Guillain-Barré syndrome: laboratory confirmation of herpes viruses in 41 cases. Ann Neurol 1981;9:44-5.